The groundbreaking approach of the medication represents a significant development in the management of type 2 diabetes. Different to existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 https://tirzepatidepeptide253019.theisblog.com/42443804/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment